p53 mutations have no additional prognostic value over stage in bladder cancer.

Evidence is accumulating that the tumour-suppressor gene p53 is involved in the development of bladder cancer. Therefore we studied p53 mutations in 47 bladder cancers obtained from 45 patients using polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis. Eight out of...

Descripción completa

Detalles Bibliográficos
Autores principales: Vet, J. A., Bringuier, P. P., Poddighe, P. J., Karthaus, H. F., Debruyne, F. M., Schalken, J. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033347/
https://www.ncbi.nlm.nih.gov/pubmed/8080737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033347/
https://www.ncbi.nlm.nih.gov/pubmed/8080737

Ejemplares similares